Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

Background The CLARITY and CLARITY Extension studies demonstrated that treatment of relapsing–remitting multiple sclerosis (RRMS) with cladribine tablets (CT) results in significant clinical improvements, compared with placebo. This paper presents the key magnetic resonance imaging (MRI) findings fr...

Celý popis

Podrobná bibliografia

Vydané v:	Therapeutic advances in neurological disorders Ročník 11; s. 1756285617753365
Hlavní autori:	Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London, England SAGE Publications 01.01.2018 SAGE PUBLICATIONS, INC SAGE Publishing
Edícia:	Therapeutic Advances in Neurological Disorders
Predmet:	Life Sciences Magnetic resonance imaging Multiple sclerosis NMR Nuclear magnetic resonance Original Research relapsing–remitting multiple sclerosis magnetic resonance imaging cladribine extension study relapsing-remitting multiple sclerosis
ISSN:	1756-2864, 1756-2856, 1756-2864
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!